Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1487.3000 8.60 (0.58%)
NSE May 08, 2026 15:31 PM
Volume: 1.0M
 

logo
Aurobindo Pharma Ltd.
07 Nov 2025
1487.30
0.58%
buy
by Axis Direct
Target: 1345 | Target met
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
 
Number of FII/FPI investors increased from 698 to 749 in Mar 2026 qtr.
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - May 8, 2026
The Baseline | 08 May 2026
Market closes lower amid rising tensions in the Strait of Hormuz
Trendlyne Marketwatch | 08 May 2026
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020